2013 Archived Content

Keynote Speakers

Stuart SchreiberTowards a Patient-Based Drug Discovery

Stuart L. Schreiber, Ph.D.

Director, Chemical Biology, Founding Member, Broad Institute of Harvard and MIT; Howard Hughes Medical Institute Investigator; Morris Loeb Professor of Chemistry and Chemical Biology, Harvard University

Paul FeldmanEnteroendocrine Drug Discovery for Treatment of Metabolic Diseases

Paul L. Feldman, Ph.D.

Senior Vice President, GlaxoSmithKline

For complete Keynote details, click here  

Event Features

  • 12 Scientific & Technical Conferences
  • 150+ Scientific Presentations
  • 10 Conference
    Short Courses
  • 30+ Interactive Breakout Discussion Groups
  • Exclusive Exhibit & Poster Viewing
  • Dedicated Networking Opportunities
  • Interactive Roundtable, Breakout & Panel Discussions

Hotel & Travel

Westin Boston Waterfront
425 Summer Street
Boston, MA 02210

Google Map | More Travel Info 

2013 Wrap Up

DOT Video Wrap Up 

Pharma’s leading targeting event delivers record attendance: 30% growth
over 2012

Next Event to Take Place October 8-10, 2014 in Boston

Discovery on Target would like to thank the 800+ speakers, attendees, sponsors and exhibitors who came to Boston for this year’s annual event. The event drew a record number of attendees from 24 countries networking and discussing current and emerging ‘hot’ drug targets for the pharmaceutical industry.

Read More

Student Fellowships

Fellowship applications for this conference are no longer being accepted on this site. If you wish to apply, please email Jamie Ring at jring@healthtech.com for details.


Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 

2014 Discovery on Target Brochure  

 green arrow FINAL BROCHURE 



green arrow VIEW ALL SPONSORS 



The exhibit hall was sold out in 2013, so please contact us early to reserve your place. To customize your sponsorship or exhibit package for 2014, contact:

Jon Stroup
Business Development Manager

2014 Discovery On Target CAG 



October 8 – 9

Targeting Epigenetic Readers and
Chromatin Remodelers

Targeting the Ubiquitin Proteasome System  

Big Data Analytics and Solutions  

GPCR-Based Drug Discovery  

RNAi for Functional Genomics Screening
– Part 1

Protein-Protein Interactions as Drug Targets  

Antibodies Against Membrane Protein Targets
– Part 1

October 9 – 10

Targeting Histone Methyltransferases and Demethylases  

Screening Drug Transporter Proteins  

Maximizing Efficiency in Discovery  

GPCR-Targeted Therapeutics  

Genome Editing for Functional Genomics
Screens – Part 2

Cancer Metabolism  

Antibodies Against Membrane Protein Targets
– Part 2


October 7

Next Generation Histone Deacetylase Inhibitors  


October 7

SC1: Designing Scalable Software Systems for Big Data Analytics  

SC2: Approaches for Biologically-Relevant Chemical Diversity  

SC3: Setting Up Effective RNAi Screens: From Design to Data to Validation  

SC4: Targeting Protein-Protein Interactions  

SC5: GPCR Structure-Based Drug Discovery  

SC6: Advances in Metagenomic Drug Discovery for New Anti-Infective Agents  

SC7: Targeting of GPCRs with Monoclonal Antibodies  

SC8: A Primer to Gene Editing: Tools and Applications  

SC9: Introduction to Targeted Covalent Inhibitors  

October 9

SC10: Setting Up Effective Functional Screens Using 3D Cell Cultures  

SC11: Integration of BDDCS and Extended Clearance Principles  

SC12: Introduction to Allosteric Modulators and Biased Ligands of GPCRs  

SC13: Introduction to Drug Metabolism